EA201591023A1 - SOLID FORM OF DERIVATIVE DIHYDROPYRIDOOXAZINE - Google Patents

SOLID FORM OF DERIVATIVE DIHYDROPYRIDOOXAZINE

Info

Publication number
EA201591023A1
EA201591023A1 EA201591023A EA201591023A EA201591023A1 EA 201591023 A1 EA201591023 A1 EA 201591023A1 EA 201591023 A EA201591023 A EA 201591023A EA 201591023 A EA201591023 A EA 201591023A EA 201591023 A1 EA201591023 A1 EA 201591023A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dihydropyridooxazine
derivative
solid form
forms
pharmaceutical compositions
Prior art date
Application number
EA201591023A
Other languages
Russian (ru)
Other versions
EA028031B1 (en
Inventor
Констанце Хурт
Кристоф Калис
Карен Каммертэн
Николя Солдерманн
Фредерик Зекри
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Priority claimed from PCT/IB2013/060412 external-priority patent/WO2014102630A1/en
Publication of EA201591023A1 publication Critical patent/EA201591023A1/en
Publication of EA028031B1 publication Critical patent/EA028031B1/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Изобретение относится к безводной кристаллической форме (1,1-диоксогексагидро-1лямбда*6*-тиопиран-4-ил)-{(S)-3-[1-(6-метокси-5-метилпиридин-3-ил)-2,3-дигидро-1Н-пиридо[3,4-b][1,4]оксазин-7-илокси]пирролидин-1-ил}метанона; фармацевтическим композициям и комбинациям, содержащим такие формы, а также к способам применения этих форм, включая их фармацевтические композиции и комбинации для лечения заболеваний.The invention relates to the anhydrous crystalline form (1,1-dioxohexahydro-1Lambda * 6 * -thiopyran-4-yl) - {(S) -3- [1- (6-methoxy-5-methylpyridin-3-yl) -2 , 3-dihydro-1H-pyrido [3,4-b] [1,4] oxazin-7-yloxy] pyrrolidin-1-yl} methanone; pharmaceutical compositions and combinations containing such forms, as well as to methods of using these forms, including their pharmaceutical compositions and combinations for the treatment of diseases.

EA201591023A 2012-11-26 2013-11-26 Solid form of dihydro-pyrido-oxazine derivative EA028031B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GC201222895 2012-11-26
PCT/IB2013/060412 WO2014102630A1 (en) 2012-11-26 2013-11-26 Solid form of dihydro-pyrido-oxazine derivative

Publications (2)

Publication Number Publication Date
EA201591023A1 true EA201591023A1 (en) 2015-09-30
EA028031B1 EA028031B1 (en) 2017-09-29

Family

ID=54198861

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591023A EA028031B1 (en) 2012-11-26 2013-11-26 Solid form of dihydro-pyrido-oxazine derivative

Country Status (8)

Country Link
JP (1) JP6310474B2 (en)
EA (1) EA028031B1 (en)
ES (1) ES2643902T3 (en)
HR (1) HRP20171573T1 (en)
HU (1) HUE036665T2 (en)
LT (1) LT2928896T (en)
MA (1) MA38100A1 (en)
SI (1) SI2928896T1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2010027002A1 (en) * 2008-09-05 2012-02-02 塩野義製薬株式会社 Fused morpholine derivative having PI3K inhibitory activity
IN2014CN04174A (en) * 2011-12-22 2015-09-04 Novartis Ag

Also Published As

Publication number Publication date
HUE036665T2 (en) 2018-07-30
SI2928896T1 (en) 2017-10-30
MA38100A1 (en) 2017-12-29
EA028031B1 (en) 2017-09-29
HRP20171573T1 (en) 2017-11-17
JP2016502531A (en) 2016-01-28
JP6310474B2 (en) 2018-04-11
LT2928896T (en) 2017-09-25
ES2643902T3 (en) 2017-11-27

Similar Documents

Publication Publication Date Title
EA201590879A1 (en) ARYL-CONDENSED AND HETEROARYL-CONDENSED LACTAMS
EA201990240A1 (en) NEW TRICYCLIC CONNECTIONS AS ANTICATIVE AGENTS
EA201492216A1 (en) Bromodomain inhibitors and their use
EA201890333A1 (en) ANTI-VIRUS COMPOUNDS
EA201391532A1 (en) Condensed Heterocyclic Compounds As Modulators of Ion Channels
EA201591166A1 (en) AUTOTAXIN INHIBITORS
EA201590868A1 (en) ANTI-VIRUS COMPOUNDS
EA201492002A1 (en) ANTI-VIRUS COMPOUNDS
EA200901157A1 (en) CONDENSED RING HETEROCYCLIC KINASE MODULATORS
EA201290980A1 (en) DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBURONIC ACID
EA201400976A1 (en) BENZODIOXANES IN COMBINATION WITH OTHER ACTIVE MEANS TO INHIBIT LEUKOTRIEN PRODUCTION
EA201790417A3 (en) Condensed Heterocyclic Compounds As Modulators of Ion Channels
EA201500298A1 (en) ALCOXYPHAZOLES AS ACTIVATORS OF SOLUBLE GUANYLATZYCLASES
EA201200176A1 (en) OXAZIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201590381A1 (en) REPLACED PYRAZOLES USED AS BLOCATORS OF N-TYPE CALCIUM CHANNELS
EA201490888A1 (en) NEW PURIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE
EA201490272A1 (en) NEW 4-PIPERIDINYL COMPOUNDS FOR USE AS TANKIRASE INHIBITORS
EA201100138A1 (en) 4-PHENOXYMETHYL-PIPERIDINES AS MODEL ACTIVITY GPR119
EA201301181A1 (en) TRIAZOLOPRYRIDINS
EA201500182A1 (en) 4-METHYL-2,3,5,9,9b-PENTAASACYCLOPENT [a] NAFTAIL
EA201170356A1 (en) POLYMORPHIC AND AMORPHOUS FORMS OF LACOSAMIDE AND AMORPHOUS COMPOSITIONS
EA201590228A1 (en) ANTAGONISTS 5-HT3 RECEPTOR
EA201100161A1 (en) QUINUCLIDINE CARBONATE DERIVATIVES AND THEIR MEDICAL COMPOSITIONS
EA201200570A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
EA201290744A1 (en) IMIDAZO [1,2-B] [1,2,4] TRIAZINS AS C-MET INHIBITORS

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY KZ